Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apocynum Tablet is a traditional Chinese medicine (TCM) formulation primarily used for the treatment of hypertension and the prevention of cardiac hypertrophy. Manufactured by Guangdong Peace Pharmaceutical Corp, the tablet is composed of extracts from *Apocynum venetum* (Luo Bu Ma), *Chrysanthemum indicum* (wild chrysanthemum), and *Stephania tetrandra* (Fangchi). Its cardioprotective and antihypertensive effects are attributed to the inhibition of AKT and ERK1/2 phosphorylation signaling pathways. Clinical studies have supported its efficacy and safety profile in managing blood pressure and mitigating cardiac remodeling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Apocynum Tablet.